Local and systemic Complications after percutaneous Interventions in the Treatment of peripheral arterial Occlusive Disease (vol 60, pg 327, 2020)

被引:0
|
作者
Heller, A. [1 ]
Meisenbacher, K. [1 ]
Dovzhanskiy, D. [1 ]
Uhl, C. [1 ]
Billing, A. [2 ]
Boeckler, D. [1 ]
机构
[1] Univ Klinikum Heidelberg, Klin Gefasschirurg & Endovaskulare Chirurg, Neuenheimer Feld 110, D-69120 Heidelberg, Germany
[2] Sana Klinikum Offenbach, Gefasschirurg & Gefasszentrum Offenbach, Offenbach, Germany
来源
GEFASSCHIRURGIE | 2024年 / 29卷 / 02期
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:124 / 124
页数:1
相关论文
共 50 条
  • [21] Management of complications after revascularization due to peripheral arterial occlusive disease. Prophylaxis and consistent adequate therapy after timely diagnostics
    Rueckert, R. I.
    Hanack, U.
    Arones-Gomez, S.
    Yousefi, S.
    Brechtel, K.
    [J]. CHIRURG, 2015, 86 (07): : 641 - 649
  • [22] Impact of the Duration of Dual Antiplatelet Therapy in Patients with Peripheral Arterial Occlusive Disease After Percutaneous Transluminal Angioplasty on Clinical Outcomes
    Cho, Sungsoo
    Ko, Young-Guk
    Shin, Dong-Ho
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myung-Ki
    Jang, Yangsoo
    [J]. CIRCULATION, 2014, 130
  • [23] Candesartan treatment for peripheral occlusive arterial disease after stent angioplasty -: A randomised, placebo-controlled trial
    Schindler, C
    Schweizer, J
    Müller, A
    Koch, R
    Hellner, G
    Fuchs, W
    Kirch, W
    [J]. CLINICAL DRUG INVESTIGATION, 2005, 25 (02) : 89 - 97
  • [24] Candesartan Treatment for Peripheral Occlusive Arterial Disease after Stent AngioplastyA Randomised Placebo-Controlled Trial
    C. Schindler
    J. Schweizer
    A. Müller
    R. Koch
    G. Hellner
    W. Fuchs
    W. Kirch
    [J]. Clinical Drug Investigation, 2005, 25 : 89 - 97
  • [25] Comparing Percutaneous Transluminal Angioplasty and Stent Placement for Treatment of Subclavian Arterial Occlusive Disease: A Systematic Review and Meta-Analysis (vol 39, pg 652, 2016)
    Ahmed, Ahmed T.
    Mohammed, Khaled
    Chehab, Monzer
    Brinjikji, Waleed
    Murad, M. Hassan
    Cloft, Harry
    Bjarnason, Haraldur
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (06) : 983 - 983
  • [26] A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease
    Heidemann, Franziska
    Kuchenbecker, Jenny
    Peters, Frederik
    Kotov, Artur
    Marschall, Ursula
    L'Hoest, Helmut
    Acar, Laura
    Ramkumar, Niveditta
    Goodney, Philip
    Debus, Eike Sebastian
    Rother, Ulrich
    Behrendt, Christian-Alexander
    [J]. JOURNAL OF VASCULAR SURGERY, 2021, 74 (03) : 780 - 787.e7
  • [27] FUNCTIONAL RESULTS AFTER ORAL TREATMENT WITH DUSODRIL IN PERIPHERAL CHRONIC ARTERIAL OCCLUSIVE DISEASE - COMPARISON OF ANGIOGRAM, PLETHYSMOGRAM AND DOPPLER
    WEIDINGER, P
    [J]. MEDIZINISCHE WELT, 1983, 34 (17): : 531 - 534
  • [28] Reporting success rate at 12 months after percutaneous treatment for peripheral arterial disease: The impact of outcome criteria
    Muradin, GSR
    Bosch, JL
    Verstijnen, ACM
    Hunink, MGM
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (01) : 46 - 50
  • [29] Decrease in P-selectin levels in patients with hypercholesterolaemia and peripheral arterial occlusive disease after lipid-lowering treatment
    Kirk, G
    McLaren, M
    Muir, AH
    Stonebridge, PA
    Belch, JJF
    [J]. VASCULAR MEDICINE, 1999, 4 (01) : 23 - 26
  • [30] Local Intra-arterial Vasodilator Infusion in Non-Occlusive Mesenteric Ischemia Significantly Increases Survival Rate (vol 43, pg 1148, 2020)
    Winzer, Robert
    Fedders, Dieter
    Backes, Moritz
    Ittermann, Till
    Grundling, Matthias
    Mensel, Birger
    Held, Hanns-Christoph
    Kromrey, Marie-Luise
    Weitz, Jurgen
    Hoffmann, Ralf-Thorsten
    Bulow, Robin
    Kuehn, Jens-Peter
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (10) : 1687 - 1687